1. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus
- Author
-
Marilia Farignoli Romeiro, Benedito Antonio Lopes da Fonseca, Angélica Silva, Marcílio Jorge Fumagalli, Danillo Lucas Alves Espósito, Luiz Tadeu Moraes Figueiredo, Edson Zangiacomi Martinez, and William Marciel de Souza
- Subjects
0301 basic medicine ,Antibodies detection ,Enzyme-Linked Immunosorbent Assay ,Antibodies, Viral ,medicine.disease_cause ,Sensitivity and Specificity ,Neutralization ,Virus ,Immunoglobulin G ,Serology ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,SEROLOGIA ,Viral Envelope Proteins ,Antigen ,Neutralization Tests ,Virology ,medicine ,Humans ,lcsh:RC109-216 ,Chikungunya ,Antigens, Viral ,biology ,Methodology ,virus diseases ,Antibodies, Neutralizing ,Recombinant Proteins ,030104 developmental biology ,Infectious Diseases ,Immunoglobulin M ,biology.protein ,Chikungunya Fever ,Envelope protein 2 ,Antibody ,Chikungunya virus - Abstract
Background Chikungunya (CHIKV) virus is an important mosquito-borne virus causing outbreaks of acute febrile illness with arthropathy. The detection of specific antibodies against CHIKV is used for diagnosis after the acute viremic phase of the disease. However, a major challenge for serologic diagnosis of CHIKV and other alphaviruses is the cross-reactivity of antibodies to common antigens among these viruses. In the present study, we have developed an enzyme-linked immunosorbend assay using a recombinant envelope protein 2 of CHIKV produced in Escherichia coli system, as a capture antigen. Results High titers (1600 to 12,800) of anti-CHIKV antibodies were detected in human sera analyzed by the CHIKV assay, suggesting it may detect low levels of the antibodies presence. On the other side, cross-reactivity was not observed in mouse hyperimmune sera to Mayaro virus and other alphaviruses analyzed by the CHIKV immunosorbend assay, suggesting it is a CHIKV-specific test. Fifty-nine human serum samples of CHIKV infection suspected cases were tested for immunoglobulin G (IgG) and M (IgM) antibodies detection using the CHIKV immunosorbend assay. A total of 44% (26/59) of samples were positive for IgG to CHIKV, determining 89.66% sensitivity and 100% specificity when the assay is compared to a CHIKV-specific neutralization assay. In addition, 40.6% (24/59) of samples were positive for IgM, determining 92.48% sensitivity and 79.04% specificity by a Bayesian method in the absence of a gold standard. Moreover, CHIKV immunosorbend assay showed similar sensibilities to a commercial immunochromatography assay (Lumiquick, USA) for CHIKV IgG and IgM detection. Conclusion In short, we have developed a rapid, simple, specific and sensitive CHIKV immunosorbend assay for IgG and IgM detection and our results showed potential applicability on the diagnosis of infections by this virus. Electronic supplementary material The online version of this article (10.1186/s12985-018-1028-1) contains supplementary material, which is available to authorized users.
- Published
- 2018
- Full Text
- View/download PDF